Rudolf Lucas obtained his Ph.D. degree in cellular and genetic biotechnology at the University of Brussels, Belgium. Dr. Lucas became Chief Assistant in the Department of Anesthesiology, Pharmacology and Surgical Intensive Care at the University Medical Center in Geneva, Switzerland. Subsequently, he served as a Senior Visiting Scientist at the Department of Biological Chemistry at the Weizmann Institute for Science in Israel and a Vice Chair at the Department of Biochemical Pharmacology at the university of Konstanz, Germany. Dr. Lucas serves currently as an Associate Professor of Pharmacology and Toxicology at the Vascular Biology Center of the Medical College of Georgia in Augusta. He was recently elected Chair of the Molecular Pathology and Functional Genomics scientific group of the European Respiratory Society. Over the past 15 years, Dr. Lucas has been investigating the role of the proinflammatory cytokines in ARDS and permeability edema. His current research focuses on the regulation of alveolar epithelial sodium channels by tumor necrosis factor and has resulted in the identification of a novel domain of the cytokine, that is, the lectin-like domain, which is spatially distinct from the receptor binding sites, and which is implicated in the activation of pulmonary edema reabsorption.
Biography Updated on 29 March 2011